ETIOTROPIC THERAPY OF VIRAL HEPATITIS

ETIOTROPIC THERAPY OF VIRAL HEPATITIS

Treatment of chronic viral hepatitis is not a fully resolved problem, especially in children. There are no convincing criteria for recovery. The paper presents various schemes used for etiotropic therapy of viral hepatitis at the present stage — interferons and antiviral drugs. For the treatment of...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. B. Chuelov, A. L. Rossina, V. F. Uchaikin
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2017-09-01
Series:	Детские инфекции (Москва)
Subjects:	viral hepatitis chronic hepatitis antiviral therapy
Online Access:	https://detinf.elpub.ru/jour/article/view/306
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Problematic issues of the effectiveness of treatment of patients with chronic viral hepatitis C according to the State program and the ways of their solution.
by: L. R. Shostakovych-Koretska, et al.
Published: (2018-11-01)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Efficacy of Alendronate and Cholecalciferol Combination in the Treatment of Osteoporosis in Patients with Chronic Viral Hepatitis Receiving Antiviral Therapy: Report of Two Cases
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

Viral hepatitis in children: state and prospects for solving the problem
by: L. G. Goriacheva, et al.
Published: (2021-12-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

Viral hepatitis
by: D. Brink
Published: (2006-09-01)

Chronic viral hepatitis B and D in pregnant women: course and outcomes (review)
by: M. D. Akhmedova, et al.
Published: (2021-07-01)

Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

The level of expression of miR-196a in patients with chronic viral hepatitis C with the first genotype of HCV according to previous experience of antiviral therapy.
by: L. R. Shostakovych-Koretskaya, et al.
Published: (2020-07-01)

Effectiveness of combined antyviral therapy in children with chronic hepatitis C
by: G. P. Martynova, et al.
Published: (2014-09-01)

Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis
by: M. V. Chistyakova, et al.
Published: (2019-07-01)

Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01)

Modern aspects of anti-viral therapy for hepatitis D
by: A. S. Zheleznova, et al.
Published: (2024-09-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)

Viral load in chronic hepatitis b: correlation with laboratory and morphological parameters
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Clinical-epidemiological and pathogenetic features of viral hepatitis C in the hemodialysis departments
by: R. N. Akalaev, et al.
Published: (2019-12-01)

CHOLESTASIS IN ACUTE AND CHRONIC VIRAL HEPATITIS
by: V. F. Uchaikin, et al.
Published: (2015-08-01)

Viral hepatitis B and C: similarities and difference
by: M. S. Karyagina, et al.
Published: (2021-06-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Vertical transmission of hepatitis B: the real and imaginary danger
by: M. A. Belopolskaya
Published: (2015-04-01)

Momentum towards simplifying and expanding treatment for chronic hepatitis B: The body of evidence continues to grow: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Robert J. Wong
Published: (2025-04-01)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Chronic Hepatitis B In Elite Athletes
by: T. H. Nguyen, et al.
Published: (2025-03-01)

Cardiac hemodynamic disorders in patients with active chronic viral hepatitis and the effectiveness of antiviral therapy
by: M. V. Chistyakova, et al.
Published: (2020-12-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
by: O. L. Sobolevskaya
Published: (2014-09-01)

New drugs in the treatment of chronic hepatitis C
by: R. Jimenez Galan, et al.
Published: (2014-04-01)

Minimization of Endogenous Intoxication Syndrome by Individual Choice of Drugs for Therapy of Chronic Hepatitis
by: D. K. Vasilyeva, et al.
Published: (2020-05-01)

Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy
by: Bingqing Yang, et al.
Published: (2025-05-01)

Monitoring of patients with chronic hepatitis B without liver cirrhosis while determining the tactics of treatment
by: O. V. Riabokon, et al.
Published: (2018-09-01)

Health-related quality of life in patients with chronic hepatitis C during combined antiviral therapy
by: V. L. Rozina, et al.
Published: (2019-12-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Doppler Examination Informativity in Children with Chronic Viral Hepatitis
by: F. I. Inoyatova, et al.
Published: (2015-10-01)